Turning foes to friends: targeting cancer-associated fibroblasts

X Chen, E Song - Nature reviews Drug discovery, 2019 - nature.com
Current paradigms of cancer-centric therapeutics are usually not sufficient to eradicate the
malignancy, as the cancer stroma may prompt tumour relapse and therapeutic resistance …
被引用次数：1415 相关文章

Turning foes to friends: targeting cancer-associated fibroblasts.

X Chen, E Song - Nature reviews. Drug Discovery, 2019 - europepmc.org
Current paradigms of cancer-centric therapeutics are usually not sufficient to eradicate the
malignancy, as the cancer stroma may prompt tumour relapse and therapeutic resistance …

[引用][C] Turning foes to friends: targeting cancer-associated fibroblasts

X Chen, E Song - Nature Reviews Drug Discovery, 2018 - cir.nii.ac.jp
Turning foes to friends: targeting cancer-associated fibroblasts | CiNii Research CiNii 国立
情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす …

Turning foes to friends: targeting cancer-associated fibroblasts.

X Chen, E Song - Nature Reviews Drug Discovery, 2019 - go.gale.com
Current paradigms of cancer-centric therapeutics are usually not sufficient to eradicate the
malignancy, as the cancer stroma may prompt tumour relapse and therapeutic resistance …

Turning foes to friends: targeting cancer-associated fibroblasts

X Chen, E Song - Nature reviews. Drug discovery, 2019 - pubmed.ncbi.nlm.nih.gov
Current paradigms of cancer-centric therapeutics are usually not sufficient to eradicate the
malignancy, as the cancer stroma may prompt tumour relapse and therapeutic resistance …

Turning foes to friends: targeting cancer-associated fibroblasts

X Chen, E Song - Nature Reviews. Drug Discovery, 2019 - hero.epa.gov
Current paradigms of cancer-centric therapeutics are usually not sufficient to eradicate the
malignancy, as the cancer stroma may prompt tumour relapse and therapeutic resistance …